98 related articles for article (PubMed ID: 28871943)
1. [Immunization with Bifidobacterium bifidum-vectored OprI vaccine of Pseudomonas aeruginosa enhances inhibitory effect on P. aeruginosa in mice].
Liu X; Li W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Aug; 33(8):1040-1044. PubMed ID: 28871943
[TBL] [Abstract][Full Text] [Related]
2. [Construction of recombinant Bb(pGEX-OprF-I) vaccine of Pseudomonas aeruginosa and its protection elicited in mice].
Liang C; Li W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jul; 35(7):589-594. PubMed ID: 31537242
[TBL] [Abstract][Full Text] [Related]
3. [Study on Construction of Recombinant Bb-pGEX-
Liu X; Li WG; Luo GX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):13-17. PubMed ID: 29737082
[TBL] [Abstract][Full Text] [Related]
4. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
5. [Dynamic changes of proliferation, subsets and apoptosis of splenocytes from BALB/c mice immunized with recombinant Bb(pGEX-Sj26GST-Sj32) vaccine against Schistosoma japonicum].
Xiang J; Li W; Zhang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1129-32. PubMed ID: 24200056
[TBL] [Abstract][Full Text] [Related]
6. Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
Finke M; Duchêne M; Eckhardt A; Domdey H; von Specht BU
Infect Immun; 1990 Jul; 58(7):2241-4. PubMed ID: 2114360
[TBL] [Abstract][Full Text] [Related]
7. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
[TBL] [Abstract][Full Text] [Related]
8. [Changes in splenocyte proliferation, subsets and cytokine production in mice immunized with recombinant vaccine Bifidobacterium bifidum (pGEX-Sj32) of Schistosoma japonicum].
Tan J; Li W; Qin T
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb; 35(2):202-7. PubMed ID: 25736113
[TBL] [Abstract][Full Text] [Related]
9. Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.
Mansouri E; Blome-Eberwein S; Gabelsberger J; Germann G; von Specht BU
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):161-6. PubMed ID: 12832120
[TBL] [Abstract][Full Text] [Related]
10. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
Weimer ET; Lu H; Kock ND; Wozniak DJ; Mizel SB
Infect Immun; 2009 Jun; 77(6):2356-66. PubMed ID: 19349426
[TBL] [Abstract][Full Text] [Related]
11. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
[TBL] [Abstract][Full Text] [Related]
12. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
[TBL] [Abstract][Full Text] [Related]
13. [Dynamic changes of immune responses in BALB/c mice immunized with a recombinant Bb(pGEX-Sj14-3-3) vaccine of Schistosoma japonicum].
Zhang N; Li W; Xiang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):685-9. PubMed ID: 23837975
[TBL] [Abstract][Full Text] [Related]
14. Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.
Arnold H; Bumann D; Felies M; Gewecke B; Sörensen M; Gessner JE; Freihorst J; von Specht BU; Baumann U
Infect Immun; 2004 Nov; 72(11):6546-53. PubMed ID: 15501786
[TBL] [Abstract][Full Text] [Related]
15. [Dynamic observation on splenocyte subsets in mice immunized with recombinant Bb-Eg95-EgA31 vaccine of Echinococcus granulosus].
Zhou BY; Chen YT; Li WG; Yang M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):764-6. PubMed ID: 21302436
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
Mansouri E; Gabelsberger J; Knapp B; Hundt E; Lenz U; Hungerer KD; Gilleland HE; Staczek J; Domdey H; von Specht BU
Infect Immun; 1999 Mar; 67(3):1461-70. PubMed ID: 10024596
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers.
von Specht BU; Lücking HC; Blum B; Schmitt A; Hungerer KD; Domdey H
Vaccine; 1996 Aug; 14(12):1111-7. PubMed ID: 8911006
[TBL] [Abstract][Full Text] [Related]
18. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.
DiGiandomenico A; Rao J; Goldberg JB
Infect Immun; 2004 Dec; 72(12):7012-21. PubMed ID: 15557624
[TBL] [Abstract][Full Text] [Related]
19. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
[TBL] [Abstract][Full Text] [Related]
20. Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by recombinant P. aeruginosa lipoprotein I and lipoprotein I-specific monoclonal antibodies.
Finke M; Muth G; Reichhelm T; Thoma M; Duchêne M; Hungerer KD; Domdey H; von Specht BU
Infect Immun; 1991 Apr; 59(4):1251-4. PubMed ID: 1706316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]